GB9715380D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9715380D0
GB9715380D0 GB9715380A GB9715380A GB9715380D0 GB 9715380 D0 GB9715380 D0 GB 9715380D0 GB 9715380 A GB9715380 A GB 9715380A GB 9715380 A GB9715380 A GB 9715380A GB 9715380 D0 GB9715380 D0 GB 9715380D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9715380A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB9715380A priority Critical patent/GB9715380D0/en
Publication of GB9715380D0 publication Critical patent/GB9715380D0/en
Priority to CNB988044765A priority patent/CN1188415C/en
Priority to SK1446-99A priority patent/SK285991B6/en
Priority to NZ338075A priority patent/NZ338075A/en
Priority to IL15764598A priority patent/IL157645A0/en
Priority to CZ0376799A priority patent/CZ299633B6/en
Priority to EA199900866A priority patent/EA002057B1/en
Priority to IL15764798A priority patent/IL157647A0/en
Priority to JP54654398A priority patent/JP3563078B2/en
Priority to YUP-524/99A priority patent/RS50118B/en
Priority to IL13227698A priority patent/IL132276A0/en
Priority to PL98336586A priority patent/PL336586A1/en
Priority to EP98924132A priority patent/EP0977756A1/en
Priority to CNB2004100685255A priority patent/CN1281588C/en
Priority to US09/402,229 priority patent/US6723719B1/en
Priority to PCT/EP1998/002257 priority patent/WO1998049166A1/en
Priority to KR10-2002-7006773A priority patent/KR100390612B1/en
Priority to KR10-1999-7009887A priority patent/KR100441229B1/en
Priority to IDW991261A priority patent/ID22834A/en
Priority to CA002288910A priority patent/CA2288910C/en
Priority to AU76445/98A priority patent/AU730670B2/en
Priority to IL15764698A priority patent/IL157646A0/en
Priority to BR9810233-8A priority patent/BR9810233A/en
Priority to TR1999/02646T priority patent/TR199902646T2/en
Priority to EA200100504A priority patent/EA004315B1/en
Priority to PA19988450401A priority patent/PA8450401A1/en
Priority to TNTNSN98053A priority patent/TNSN98053A1/en
Priority to DZ980076A priority patent/DZ2465A1/en
Priority to MA25040A priority patent/MA24529A1/en
Priority to APAP/P/1998/001228A priority patent/AP1002A/en
Priority to ARP980101889A priority patent/AR015595A1/en
Priority to CO98022516A priority patent/CO4940472A1/en
Priority to HR980222A priority patent/HRP980222B1/en
Priority to PE1998000312A priority patent/PE68699A1/en
Priority to IS5200A priority patent/IS5200A/en
Priority to IL132276A priority patent/IL132276A/en
Priority to OA9900234A priority patent/OA11168A/en
Priority to BG103828A priority patent/BG103828A/en
Priority to NO19995211A priority patent/NO314585B1/en
Priority to HK00107029A priority patent/HK1027808A1/en
Priority to IL157647A priority patent/IL157647A/en
Priority to IL157645A priority patent/IL157645A/en
Priority to IL157646A priority patent/IL157646A/en
Priority to JP2004059879A priority patent/JP4036836B2/en
Priority to US10/808,027 priority patent/US6916927B2/en
Pending legal-status Critical Current

Links

GB9715380A 1997-04-25 1997-07-22 Therapeutic agents Pending GB9715380D0 (en)

Priority Applications (45)

Application Number Priority Date Filing Date Title
GB9715380A GB9715380D0 (en) 1997-07-22 1997-07-22 Therapeutic agents
SK1446-99A SK285991B6 (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones, process and intermediates for preparing them, their use and pharmaceutical or veterinary compositions based on them
BR9810233-8A BR9810233A (en) 1997-04-25 1998-04-10 Pyrozolpyrimidinones that inhibit guanosine phosphodiesterase 3`, 5`- cyclic monosphophate type 5 (cgmp pde5) for the treatment of sexual dysfunction.
EA200100504A EA004315B1 (en) 1997-04-25 1998-04-10 Novel sulfonylbenzoic acids and process for preparation of 4-benzamido-pyrazolo-5-carboxamides and use thereof
NZ338075A NZ338075A (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PED5) for the treatment of sexual dysfunction
TR1999/02646T TR199902646T2 (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones for the treatment of sexual disorder.
CZ0376799A CZ299633B6 (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones, intermediates for their preparation and pharmaceutical and veterinary compositions based thereon
EA199900866A EA002057B1 (en) 1997-04-25 1998-04-10 PYRAZOLLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDES) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
IL15764798A IL157647A0 (en) 1997-04-25 1998-04-10 INTERMEDIATES FOR PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
JP54654398A JP3563078B2 (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones that inhibit type 5 cyclic guanosine 3 ', 5'-monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction
YUP-524/99A RS50118B (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phospho-diesterase (cgmp pde5) for the treatment of sexual dysfunction
IL13227698A IL132276A0 (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cgmp pde5) for the treatment of sexual dysfunction
PL98336586A PL336586A1 (en) 1997-04-25 1998-04-10 Pyrazoylpyrimidinones inhibiting the cyclic guanosine 3',5'-monophosphate phosphodiesterase of type 5 (cgmp pde5) for treating sexual disorders
EP98924132A EP0977756A1 (en) 1997-04-25 1998-04-10 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
CNB2004100685255A CN1281588C (en) 1997-04-25 1998-04-10 Novel intermediate for prepn. of pyrazolopyrimidinones
US09/402,229 US6723719B1 (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′—monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction
PCT/EP1998/002257 WO1998049166A1 (en) 1997-04-25 1998-04-10 PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
KR10-2002-7006773A KR100390612B1 (en) 1997-04-25 1998-04-10 Method of Producing the Intermediate for Use in the Preparation of Pyrazolopyrimidinones Which Inhibit Type 5 Cyclic Guanosine 3',5'-Monophosphate Phosphodiesterase for the Treatment of Sexual Dysfunction
KR10-1999-7009887A KR100441229B1 (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones Which Inhibit Type 5 Cyclic Guanosine 3',5'-Monophosphate Phosphodiesterase (cGMP PDE5) for the Treatment of Sexual Dysfunction
IDW991261A ID22834A (en) 1997-04-25 1998-04-10 PIRAZOLOPIMIDINONA FOR SEXUAL ARRANGEMENT
CA002288910A CA2288910C (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones for sexual dysfunction
AU76445/98A AU730670B2 (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction
IL15764698A IL157646A0 (en) 1997-04-25 1998-04-10 INTERMEDIATES FOR PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
CNB988044765A CN1188415C (en) 1997-04-25 1998-04-10 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for treatment of sexual dysfunction
IL15764598A IL157645A0 (en) 1997-04-25 1998-04-10 INTERMEDIATES FOR PYRAZOLOPYRIMIDINONES WHICH INHIBIT TYPE 5 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE (cGMP PDE5) FOR THE TREATMENT OF SEXUAL DYSFUNCTION
PA19988450401A PA8450401A1 (en) 1997-04-25 1998-04-20 PIRAZOLOPIRIMIDONAS FOR SEXUAL DYSFUNCTION
TNTNSN98053A TNSN98053A1 (en) 1997-04-25 1998-04-22 NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.
MA25040A MA24529A1 (en) 1997-04-25 1998-04-22 NOVEL PYRAZOLOPYRIMIDINONES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM.
DZ980076A DZ2465A1 (en) 1997-04-25 1998-04-22 New pyrazolopyrimidinones process for their preparation and compositions containing them.
ARP980101889A AR015595A1 (en) 1997-04-25 1998-04-23 COMPOUNDS DERIVED FROM PIRAZOLO [4,3-D] -PIRIMIDIN-7-ONAS, PHARMACEUTICAL COMPOSITIONS, VETERINARY FORMULATION, USE OF SUCH COMPOUNDS IN THE PREPARATION OF COMPOSITION AND FORMULATIONS. PROCEDURES FOR USE, INTERMEDIATE COMPOUNDS, PROCESS FOR THE PREPARATION OF COMPOUNDS.
CO98022516A CO4940472A1 (en) 1997-04-25 1998-04-23 PIRAZOLOPIRIMIDONAS FOR SEXUAL DYSFUNCTION
APAP/P/1998/001228A AP1002A (en) 1997-04-25 1998-04-23 Pyrazolopyrimidinones for sexual dysfunction.
HR980222A HRP980222B1 (en) 1997-04-25 1998-04-24 Pyrazolopyrimidinones for the treatment of sexual disfunction
PE1998000312A PE68699A1 (en) 1997-04-25 1998-04-24 PIRAZOLOPIRIMIDONAS FOR SEXUAL DYSFUNCTION
IS5200A IS5200A (en) 1997-04-25 1999-09-28 Pyrazolopyrimidinone that stimulates type 5 cyclic guanosine 3 ', 5' - monophosphate phosphodiesterase (cGMPPDE5) for the treatment of sexual disorders
IL132276A IL132276A (en) 1997-04-25 1999-10-07 5 - [2 - alkoxy - 5 - (piperazin - 1 -
OA9900234A OA11168A (en) 1997-04-25 1999-10-22 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3', 5'-monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction
BG103828A BG103828A (en) 1997-04-25 1999-10-22 PYRAZOLOPYRIMIDINONS INHIBITING CYCLIC GUANOSINE 3', 5'-MONOPHOSPHATE PHOSPHODIESTERASE TYPE 5 (cGMP PDE5), FOR THE TREATMENT OF SEXUAL DYSFUNCTION
NO19995211A NO314585B1 (en) 1997-04-25 1999-10-25 Pyrazole pyrimidinones inhibiting cyclic guanosine-3 ', 5'-monophosphate phosphodiesterase type 5 (cGMP PDE5), for the treatment of sexual dysfunction
HK00107029A HK1027808A1 (en) 1997-04-25 2000-11-03 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cgmp pde5) for the treatment of sexual dysfunction.
IL157647A IL157647A (en) 1997-04-25 2003-08-28 5-[2-alkoxy-5-halosulphonyl-phenyl]-1,3-(2,3-)disubstituted-1,6-(2,6)-dihydro-7h-pyrazolo[4,3-d]pyrimidin-7-ones
IL157645A IL157645A (en) 1997-04-25 2003-08-28 4-[2-alkoxy-5-((4-alkylpiperazino)sulphonyl)benzamido]-1,3 (or 1,5)-disubstituted-pyrazole- carboxamides
IL157646A IL157646A (en) 1997-04-25 2003-08-28 5-(2-alkoxyphenyl)-6,7-dihydro-1,3(and 2,3)-disubstituted pyrazolo[4,3-d] pyrimidin-7-ones
JP2004059879A JP4036836B2 (en) 1997-04-25 2004-03-03 Method for producing pyrazolopyrimidinone intermediates that inhibit type 5 cyclic guanosine 3 ', 5'-monophosphate phosphodiesterase (cGMPPDE5) for the treatment of sexual dysfunction
US10/808,027 US6916927B2 (en) 1997-04-25 2004-03-23 Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3′,5′-monophosphate phosphodiesterase (cGMP-PDE5) for the treatment of sexual dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715380A GB9715380D0 (en) 1997-07-22 1997-07-22 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9715380D0 true GB9715380D0 (en) 1997-09-24

Family

ID=10816219

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9715380A Pending GB9715380D0 (en) 1997-04-25 1997-07-22 Therapeutic agents

Country Status (1)

Country Link
GB (1) GB9715380D0 (en)

Similar Documents

Publication Publication Date Title
GB9725782D0 (en) Therapeutic agents
GB9708484D0 (en) Therapeutic agents
GB9718833D0 (en) Therapeutic agents
GB9708945D0 (en) Therapeutic agents
GB9601724D0 (en) Therapeutic agents
GB9704948D0 (en) Therapeutic agents
GB9702524D0 (en) Therapeutic agents
GB9711753D0 (en) Therapeutic agents
GB9713707D0 (en) Therapeutic agents
GB9715977D0 (en) Therapeutic agents
GB9711114D0 (en) Therapeutic agents
GB9600235D0 (en) Therapeutic agents
HUP0300615A3 (en) Therapeutic agents
GB9723544D0 (en) Therapeutic agents
GB9702392D0 (en) Therapeutic agents
GB9700555D0 (en) Therapeutic agents
GB9725126D0 (en) Therapeutic agents
GB9718254D0 (en) Therapeutic agents
GB9716463D0 (en) Therapeutic agents
GB9716457D0 (en) Therapeutic agents
GB9723741D0 (en) Therapeutic agents
GB9716482D0 (en) Therapeutic agents
GB9720998D0 (en) Therapeutic agents
GB9716491D0 (en) Therapeutic agents
GB9722954D0 (en) Therapeutic agents